Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call
February 16 2017 - 7:30AM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
financial results for the company’s fourth quarter and year ended
December 31, 2016 will be released before the market opens on
Wednesday, March 1, 2017. The Pacira management team will host a
conference call to discuss the company’s financial results and
recent and upcoming developments on Wednesday, March 1, 2017, at
8:30 a.m. ET. The call can be accessed by dialing 1-877-845-0779
(domestic) or 1-720-545-0035 (international) ten minutes prior to
the start of the call and providing the Conference ID 40628335.
A replay of the call will be available approximately two hours
after the completion of the call and can be accessed by dialing
1-855-859-2056 (domestic) or 1-404-537-3406 (international) and
providing the Conference ID 40628335. The replay of the call will
be available for two weeks from the date of the live call.
The live, listen-only webcast of the conference call can also be
accessed by visiting the “Investors & Media” section of the
company’s website at investor.pacira.com. A replay of the webcast
will be archived on the Pacira website for two weeks following the
call.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Investor Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco, (973) 451-4030
susan.mesco@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Sep 2023 to Sep 2024